Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
Tickers
BNTX
IMAB
VSTM
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Truth About IPO Investing
September 02, 2023
Tickers
ABBV
CUE
PLSE
SLRN
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15%
September 02, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
August 30, 2023
Tickers
BDX
GEHC
IBB
IHI
Tags
Stocks / Equities
Pharma/Biotech
Mutual Funds
From
TalkMarkets
Chart Of The Day: AptarGroup Delivers Healthcare
August 28, 2023
Tickers
ATR
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
The 7 ETFs In The Fringe Portfolio Were, On Average, Up Last Week
August 27, 2023
Tickers
MSOS
POTX
PSIL
SGDJ
Tags
Consumer Goods
ETFs
Healthcare
From
TalkMarkets
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
August 26, 2023
Tickers
HCM
IVBXF
MRNA
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week
August 25, 2023
Tickers
ATAI
CMPS
IXHL
MNMD
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Three Lessons For Investing In Biotech Companies
August 23, 2023
Tickers
IBB
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Tuesday Talk: Monday Rebound
August 22, 2023
Tickers
BITCOMP
DIA
MRNA
NDX
Tags
Market News
Cryptocurrencies
Stocks / Equities
From
TalkMarkets
Gene Therapy Breakthroughs On The Horizon
August 21, 2023
Tickers
CRSP
VRTX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Tickers
ABBV
BMY
GILD
IBB
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Largest Psychedelic Compound-Based R&D Stocks Continue Downward Trend
August 20, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
Tickers
ARQT
GDTC
MRK
ONBI
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
How To Invest In The Healthcare Sector
August 19, 2023
Tickers
IMGN
MRSN
SGEN
TGT
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
Thoughts For Thursday: Slipsliding, Sideways
August 17, 2023
Tickers
AMD
JNJ
SPX
TSLA
Tags
Market News
Consumer Goods
Services
From
TalkMarkets
So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index
August 13, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
ETFs
Market News
Stocks / Equities
From
TalkMarkets
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
Tickers
AZN
BGNE
BMY
BNTX
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
August 05, 2023
Tickers
ABVC
AZN
CASI
LIAN
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
S&P 500 Forecast: Resilience In Earnings Season
August 02, 2023
Tickers
CAT
PFE
SBUX
Tags
Consumer Goods
Market News
Capital & Industrial Goods
From
TalkMarkets
Arnold Pharmaceuticals Sprints To Nasdaq
August 02, 2023
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Correction In August?
August 01, 2023
Tags
Consumer Goods
Market News
Stocks / Equities
From
TalkMarkets
The Canadian Cannabis Report- Monday, July 31
July 31, 2023
Tickers
CGC
TLRY
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
July Summary: Largest Psychedelic Compound-Based R&D Stocks Up 16%
July 30, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs
July 29, 2023
Tickers
ASCLF
ILMN
REGMF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: What's Cooking At Dr. Reddy's Lab
July 28, 2023
Tickers
RDY
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Big Weeks Ahead For MedTech And Life Science Stocks
July 24, 2023
Tickers
ABBV
BMY
BSX
DHR
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
Governor DeSantis Says He Would Sue the Drug Company Gilead for Trying to Save Lives
July 23, 2023
Tickers
GILD
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD
July 23, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
July 22, 2023
Tickers
BNTX
CASI
NVS
VBIZF
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.